RA Capital Management, LLC

Filings by RA Capital Management, LLC span 20 companies, the busiest being Sequenom Inc, Achillion Pharmaceuticals Inc and Sangamo Therapeutics, Inc. Between 21 December 2006 and 17 September 2019, the trades on record add up to 726 filings.

Both buying and selling appear: 469 purchases worth €319.4M, against 229 sales worth €234.8M. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 13 share grants and 1 option exercise. Since January 2019: 3 purchases and no sales on the market.

In size, the median ticket on the buying side is €19k. Of 21 purchases, 9 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. After 41 purchases with a full 90-day history, the hit rate stands at 32% and the median 90-day move at -12.2%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 17 September 2019, reports a transaction in Satsuma Pharmaceuticals, Inc. The last purchase on record was published on 17 September 2019, which is 2,609 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.